Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

924
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
924
Principles of Drug Action01:24

Principles of Drug Action

5.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

471
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
471
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Prodrugs01:30

Prodrugs

2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total drug's last stand on phospholipidosis: Unbound drug rules!

Drug metabolism and disposition: the biological fate of chemicals·2025
Same author

Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Insights on Volume of Distribution of Acids.

Journal of medicinal chemistry·2025
Same author

Correction to "Dose Predictions for Drug Design".

Journal of medicinal chemistry·2025
Same author

Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.

Journal of medicinal chemistry·2024
Same author

Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors.

Journal of medicinal chemistry·2024

Related Experiment Video

Updated: May 21, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.2K

Free Drug Concepts: A Lingering Problem in Drug Discovery

Peter J H Webborn, Kevin Beaumont, Iain J Martin

    Journal of Medicinal Chemistry
    |March 21, 2025
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
    06:26

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

    Published on: May 16, 2021

    4.7K
    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
    07:50

    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

    Published on: July 16, 2012

    14.1K

    Related Experiment Videos

    Last Updated: May 21, 2025

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    9.2K
    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
    06:26

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

    Published on: May 16, 2021

    4.7K
    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
    07:50

    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

    Published on: July 16, 2012

    14.1K